0001485003-16-000178.txt : 20160922
0001485003-16-000178.hdr.sgml : 20160922
20160922165822
ACCESSION NUMBER: 0001485003-16-000178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeCillis Arthur
CENTRAL INDEX KEY: 0001685148
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161898068
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 1ST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_147457788976789.xml
FORM 4
X0306
4
2016-09-20
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001685148
DeCillis Arthur
C/O ELEVEN BIOTHERAPEUTICS, INC.
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
0
1
0
0
Chief Medical Officer
Stock Option
3.37
2016-09-20
4
A
0
100000
0
A
2026-09-19
Common Stock
100000.0
100000
D
25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.
/s/ Arthur P. DeCillis, M.D.
2016-09-22